Global Regulatory Partners, Inc.
Suzan Davis, Pharm.D, EMBA, RAC US, RAC EU, MSRA, has over two decades of experience in regulatory affairs for pharmaceutical, biotech, and medical device companies. Currently serving as President & CEO of Global Regulatory Partners-LLC since January 2010, Suzan has previously held leadership roles including Chief Executive Officer at FORUM Pharmaceuticals and Senior Regulatory Affairs Consultant positions at Genzyme and Pfizer. Notable contributions include regulatory strategy development, clinical trial submissions, and orphan drug application preparations across multiple global markets. Educational qualifications include an MBA and a Master's in Regulatory Affairs from Northeastern University, as well as a degree from Université Paris 1 Panthéon-Sorbonne.
This person is not in any teams
Global Regulatory Partners, Inc.
Global Regulatory Partners Group (GRP Group) is a global market access solution provider. GRP Group headquarters is located in USA, and includes 6 companies: GRP-USA, GRP-Brazil, GRP-China, GRP-Japan, GRP-Mexico and GRP-Korea. The GRP-Group offers end-to-end Regulatory Affairs, Clinical, Quality, Pharmacovigilance solutions to Medtech, Pharmaceuticals, Biotech, Cosmetics and life-consumer companies to help them access new market in record time and minimum investment, while ensuring Compliance with local regulations.